Canada Life’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Buy |
6,242
+2,192
| +54% | +$117K | ﹤0.01% | 1664 |
|
|
2025
Q1 | $164K | Hold |
4,050
| – | – | ﹤0.01% | 1735 |
|
|
2024
Q4 | $112K | Hold |
4,050
| – | – | ﹤0.01% | 1799 |
|
|
2024
Q3 | $116K | Hold |
4,050
| – | – | ﹤0.01% | 1840 |
|
|
2024
Q2 | $95K | Hold |
4,050
| – | – | ﹤0.01% | 1888 |
|
|
2024
Q1 | $102K | Hold |
4,050
| – | – | ﹤0.01% | 1922 |
|
|
2023
Q4 | $94K | Hold |
4,050
| – | – | ﹤0.01% | 1957 |
|
|
2023
Q3 | $205K | Buy |
4,050
+2,564
| +173% | +$130K | ﹤0.01% | 1851 |
|
|
2023
Q2 | $70K | Hold |
1,486
| – | – | ﹤0.01% | 1966 |
|
|
2023
Q1 | $57K | Hold |
1,486
| – | – | ﹤0.01% | 2046 |
|
|
2022
Q4 | $82K | Buy |
1,486
+901
| +154% | +$49.7K | ﹤0.01% | 2013 |
|
|
2022
Q3 | $20K | Hold |
585
| – | – | ﹤0.01% | 2259 |
|
|
2022
Q2 | $6K | Hold |
585
| – | – | ﹤0.01% | 2404 |
|
|
2022
Q1 | $9K | Hold |
585
| – | – | ﹤0.01% | 2438 |
|
|
2021
Q4 | $12K | Hold |
585
| – | – | ﹤0.01% | 2432 |
|
|
2021
Q3 | $13K | Hold |
585
| – | – | ﹤0.01% | 2485 |
|
|
2021
Q2 | $15K | Sell |
585
-903
| -61% | -$23.2K | ﹤0.01% | 2519 |
|
|
2021
Q1 | $43K | Hold |
1,488
| – | – | ﹤0.01% | 2333 |
|
|
2020
Q4 | $38K | Hold |
1,488
| – | – | ﹤0.01% | 2375 |
|
|
2020
Q3 | $46K | Hold |
1,488
| – | – | ﹤0.01% | 2199 |
|
|
2020
Q2 | $37K | Buy |
+1,488
| New | +$37K | ﹤0.01% | 2320 |
|